Aclarion, a Jeffco-based healthcare technology company, has issued a statement regarding Echo Lake Capital’s proposal to acquire the company for $4.00 per share in cash and contingent value rights. Aclarion’s Board of Directors is committed to acting in the best interests of the company and its shareholders, and will carefully evaluate the proposal.
The Board has also authorized a share repurchase program, emphasizing its belief that Aclarion’s current market valuation does not fully represent its platform’s strength and long-term potential. Aclarion highlighted that Echo Lake’s communications include assertions about governance that the Board finds misleading.
Aclarion’s Board consists of seven directors with diverse expertise relevant to industry needs. The Board is focused on continuous improvement and recently appointed five new directors over the past six years who align with Aclarion’s strategic priorities. The company has engaged Goodwin Procter LLP as legal counsel regarding the matters at hand.
This news is significant as it concerns a potential acquisition that could impact the company’s direction and valuation in the healthcare technology sector. For more details, visit the primary source at GlobeNewswire.